Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02327312 · ClinicalTrials.gov registry record · NA
Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty
A NA study, sponsored by Glaukos Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 91
- Enrollment target
NCT02327312 is a NA study that was terminated before completion, run by Glaukos Corporation. The registered enrollment target is 91 participants.
The verdict
NCT02327312, a NA study, was terminated before completion, sponsored by Glaukos Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
Study Summary
To evaluate the safety and effectiveness of Trabecular Micro-Bypass stents (two stents per study eye) vs. laser trabeculoplasty, in subjects with open angle glaucoma
Interventions
- DEVICE Stents
- PROCEDURE Laser
- DEVICE Laser Trabeculoplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2014-12-16 |
| Est. Completion | 2020-08-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02327312
The ClinicalTrials.gov registry entry for NCT02327312 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Glaukos Corporation, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Stents is the first listed.
NCT02327312 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02327312 about?
NCT02327312 is a clinical study titled "Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty". To evaluate the safety and effectiveness of Trabecular Micro-Bypass stents (two stents per study eye) vs. laser trabeculoplasty, in subjects with open angle glaucoma
What is the current status of trial NCT02327312?
This trial is currently terminated. It is a NA study. The enrollment target is 91 participants. The study started on 2014-12-16. Estimated completion is 2020-08-11.
What interventions are being tested in trial NCT02327312?
The interventions under investigation include: Stents (DEVICE), Laser (PROCEDURE), Laser Trabeculoplasty (DEVICE).
Who is sponsoring clinical trial NCT02327312?
This trial is sponsored by Glaukos Corporation, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.